“…Among the older ones, oxytocin [18], yohimbine [19] and apomorphine only the latter is currently in clinical use. Melanocortin peptides are being actively explored clinically with promising results [20]. Apomorphine (2 and 3 mg for sublingual application) is approved for clinical use in Europe and Latin America.…”